Nuveen’s Rain Oncology Inc. Common Stock RAIN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-16,731
Closed -$20.1K 3334
2023
Q4
$20.1K Buy
+16,731
New +$18.1K ﹤0.01% 3315
2022
Q2
Sell
-32,437
Closed -$223K 3553
2022
Q1
$223K Hold
32,437
﹤0.01% 3171
2021
Q4
$400K Buy
32,437
+12,475
+62% +$178K ﹤0.01% 3124
2021
Q3
$317K Buy
19,962
+8,345
+72% +$142K ﹤0.01% 3242
2021
Q2
$181K Buy
+11,617
New +$204K ﹤0.01% 3255

Nuveen's RAIN Position: Q1 2024 in Review

Nuveen sold out of Rain Oncology Inc. Common Stock (RAIN) in Q1 2024, closing a stake of 16,731 shares — an estimated $20.1K sold.

Nuveen first reported a position in RAIN in Q2 2021 and held it in 5 quarters. The position peaked at $400K in Q4 2021. 0 funds tracked by Wall St. Rank hold RAIN as of Q1 2024.

  • Nuveen reported no remaining Rain Oncology Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Nuveen sold 16,731 Rain Oncology Inc. Common Stock shares in Q1 2024, an estimated $20.1K.
  • Nuveen first reported a position in Rain Oncology Inc. Common Stock in Q2 2021 and held it in 5 quarters.
  • Nuveen's Rain Oncology Inc. Common Stock position peaked at $400K in Q4 2021.
  • 0 funds tracked by Wall St. Rank held Rain Oncology Inc. Common Stock as of Q1 2024.

Based on Nuveen's 13F filing for Q1 2024, filed 13 May 2024.